Genetic Technologies Ltd.
GENE
GENE was delisted on the 16th of October, 2024.
10 hedge funds and large institutions have $274K invested in Genetic Technologies Ltd. in 2014 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 0 closing their positions.
448% more capital invested
Capital invested by funds: $50K → $274K (+$224K)
100% more funds holding
Funds holding: 5 → 10 (+5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$74.2K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$63.5K |
| 3 |
Morgan Stanley
New York
|
+$43.4K |
| 4 |
ARTA
A.R.T. Advisors
New York
|
+$23.8K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$17.9K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VKH
1
Virtu KCG Holdings
New York
| $85K | +$63.5K | +397 | +187% |
|
|
2
Citadel Advisors
Miami,
Florida
| $65K | +$74.2K | +464 | New |
|
|
3
Morgan Stanley
New York
| $38K | +$43.4K | +271 | New |
|
|
ARTA
4
A.R.T. Advisors
New York
| $20K | +$23.8K | +149 | New |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $18K | +$17.9K | +112 | +700% |
|
|
APU
6
Alpine Partners USVI
St. Thomas,
U.S. Virgin Islands
| $16K | – | – | – |
|
|
CIM
7
Calvert Investment Management
Bethesda,
Maryland
| $15K | +$17K | +106 | New |
|
|
U
8
UBS
Zurich,
Switzerland
| $14K | +$16K | +100 | New |
|
9
Group One Trading
Chicago,
Illinois
| $2K | +$1.76K | +11 | +275% |
|
10
Citigroup
New York
| $1K | +$320 | +2 | +67% |
|
GENE Hedge Fund Activity: Q1 2014 in Review
10 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q1 2014, worth a combined $274K — up 448% from $50K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new GENE positions and 0 closed out — a net gain of 5 holders — while 4 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $74.2K.
- 10 institutional investors held Genetic Technologies Ltd. (GENE) as of Q1 2014, up from 5 in Q4 2013.
- Funds reported $274K of Genetic Technologies Ltd. stock for Q1 2014, up 448% quarter-over-quarter.
- 5 funds opened new Genetic Technologies Ltd. positions in Q1 2014 and 0 closed out, a net change of +5 holders.
- The largest Genetic Technologies Ltd. buyer in Q1 2014 was Citadel Advisors, an estimated $74.2K added.
Based on aggregated 13F filings for Q1 2014.